As President & CEO since June 2012, John has lead the turnaround and growth of Codexis, the Nasdaq-listed protein engineering company (Ticker: CDXS). Prior to Codexis, John worked in various leadership roles for more than 22 years at Albemarle Corporation, a maker of highly engineered specialty chemicals. MBA from MIT Sloan; BS Chemical Engineering from NYU/Poly; Native of New York city.